Hayek Kallen Investment Management Lowers stake in Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific (TMO) : Hayek Kallen Investment Management reduced its stake in Thermo Fisher Scientific by 1.88% during the most recent quarter end. The investment management company now holds a total of 34,424 shares of Thermo Fisher Scientific which is valued at $5,090,965 after selling 659 shares in Thermo Fisher Scientific , the firm said in a disclosure report filed with the SEC on May 9, 2016.Thermo Fisher Scientific makes up approximately 3.81% of Hayek Kallen Investment Management’s portfolio.

Other Hedge Funds, Including , Cls Investments boosted its stake in TMO in the latest quarter, The investment management firm added 269 additional shares and now holds a total of 3,910 shares of Thermo Fisher Scientific which is valued at $578,250. Thermo Fisher Scientific makes up approx 0.02% of Cls Investments’s portfolio.Td Asset Management Inc reduced its stake in TMO by selling 25,803 shares or 5.01% in the most recent quarter. The Hedge Fund company now holds 489,025 shares of TMO which is valued at $71,872,004. Thermo Fisher Scientific makes up approx 0.14% of Td Asset Management Inc’s portfolio.Pillar Pacific Capital Management boosted its stake in TMO in the latest quarter, The investment management firm added 774 additional shares and now holds a total of 57,755 shares of Thermo Fisher Scientific which is valued at $8,488,252. Thermo Fisher Scientific makes up approx 1.48% of Pillar Pacific Capital Management’s portfolio.Cryder Capital Partners Llp boosted its stake in TMO in the latest quarter, The investment management firm added 1,336 additional shares and now holds a total of 112,911 shares of Thermo Fisher Scientific which is valued at $16,287,412. Thermo Fisher Scientific makes up approx 12.41% of Cryder Capital Partners Llp’s portfolio.

Thermo Fisher Scientific closed down -1.03 points or -0.69% at $147.89 with 15,31,051 shares getting traded on Friday. Post opening the session at $148.37, the shares hit an intraday low of $147.4 and an intraday high of $149.35 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, Thermo Fisher Scientific reported $1.80 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $1.74. The company had revenue of $4294.80 million for the quarter, compared to analysts expectations of $4113.28 million. The company’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.63 EPS.

Many Wall Street Analysts have commented on Thermo Fisher Scientific. Company shares were Reiterated by Mizuho on May 3, 2016 to “Buy”, Firm has raised the Price Target to $ 163 from a previous price target of $160 .Thermo Fisher Scientific was Downgraded by Jefferies to ” Hold” on Apr 29, 2016. Company shares were Reiterated by Mizuho on Apr 4, 2016 to “Buy”, Firm has raised the Price Target to $ 160 from a previous price target of $150 .

Thermo Fisher Scientific Inc. is a provider of analytical instruments equipment reagents and consumables software and services for research manufacturing analysis discovery and diagnostics. The company operates through four segments: Life Sciences Solutions provides reagents instruments and consumables used in biological and medical research discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments provides instruments consumables software and services that are used in the laboratory; Specialty Diagnostics offers diagnostic test kits reagents culture media instruments and associated products and Laboratory Products and Services offers self-manufactured and sourced products for the laboratory.

Leave a Reply

Thermo Fisher Scientific - Is it time to Sell?

Top Brokerage Firms are advising their investors on Thermo Fisher Scientific. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.